• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- Global COVID markers decline, but hot spots remain in two regions

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/covid-19/global-covid-markers-decline-hot-spots-remain-two-regions

Global COVID markers decline, but hot spots remain in two regions


Lisa Schnirring

Today at 4:01 p.m.

COVID-19

Though COVID-19 cases and deaths continued to decline over the past 4 weeks, the World Health Organization (WHO) is tracking rises in two of its regions, South East Asia and the Eastern Mediterranean. In its weekly update today, it also noted rises in individual countries in other parts of the world.


WHO plans transition to sustained COVID management


At a WHO media briefing yesterday, Director-General Tedros Adhanom Ghebreyesus, PhD, said though the WHO is encouraged by the sustained drop in deaths, which have dropped 95% since the beginning of the year. However, he warned that some countries are seeing rises, and over the past 4 weeks, about 14,000 people died from their infections.

He also raised concerns about the large numbers of people with long COVID, estimated to affect 1 in 10 infected people, pointing for a substantial need for longer-term care.

Tedros said though officials look forward to the end of the public health emergency phase, it's clear that the virus is here to stay, and the emergence of XBB.1.16 is a reminder that the virus is still changing and is capable of causing illness and deaths.

Next week, the WHO will publish its latest strategy guide, which will help countries transition from the emergency response to longer sustained management of COVID-19, Tedros said.

Hot spots and variant shifts

Overall, cases declined 23% and deaths dropped 36% compared to the previous 28 days. The WHO repeated its caveat that the numbers are underestimates due to reduced testing and delays in reporting.

In the South East Asia region, cases over the last 4 weeks were up sharply, mainly led by rises in India and, to a lesser extent, Indonesia and Thailand. Deaths in the region also rose, mainly due to increases in India and Indonesia.

In the Eastern Mediterranean region, which includes much of the Middle East, Saudi Arabia, Qatar, and Iran, reported modest rises over the past 4 weeks, with deaths also on the rise, especially from Iran.

Elsewhere, cases were up sharply in Vietnam, which is included in the WHO's Western Pacific region.

The WHO's latest report also shows a shift in Omicron subvariant proportions. Focusing on the two variants of interest, the proportion of XBB.1.5 declined from 49.1% to 45.4% between early March and the first week of April. Meanwhile, for XBB.1.16, the proportion since early March has increased from 1.3% to 4.3%.

XBB.1.16, responsible for fueling India's spike, has now been detected in 37 countries. The WHO recently added it as the second variant of interest and released a preliminary risk assessment, which it said may become dominant in some countries due to its growth advantage and immune escape properties. However, so far, there's no evidence that infections are more severe.

In related developments, the European Centre for Disease Prevention and Control (ECDC) today in its weekly COVID snapshot said activity is decreasing or stable across most of the region, with death rates stable. Of five countries with adequate sequencing, the proportion of XBB.1.5 is 57.3%, with other XBB subvariants at 26.2%.

The latest update from the United Kingdom's Health Security Agency (HSA) said that hospital admission rates declined for all age groups, but the highest levels are still in people over age 75.

Mary Ramsay, MD, the HSA's immunization head, said the virus has not gone away and that officials continue to see thousands of cases every week. "So topping up your protection is particularly important for groups who are more vulnerable."
 
Back
Top Bottom